Advertisement
SBRA vs WELL
Which Stock Would AI Choose? Sabra Health Care REIT (SBRA) vs. Welltower (WELL) Stock Comparison
Key Takeaways
- SBRA and WELL are both healthcare real estate investment trusts (REITs) with exposure to senior housing and medical properties, though WELL operates at significantly larger scale with a market capitalization exceeding $160 billion compared to SBRA’s approximately $5 billion.
- Recent market activity shows WELL delivering stronger year-to-date and one-year total returns than SBRA, reflecting differences in portfolio size, diversification, and operational momentum.
- SBRA offers a higher dividend yield near 6 percent, supported by stable funds from operations, while WELL maintains a lower yield around 1.5 percent with greater capacity for future increases.
- Analyst consensus ratings remain positive for both, with price targets indicating upside potential, though WELL benefits from broader institutional ownership and lower relative leverage metrics in recent periods.
- Sector sentiment in healthcare REITs has been influenced by occupancy trends and acquisition activity, with SBRA highlighting recent revenue growth and WELL demonstrating sustained expansion across its platform.
- Relative positioning favors WELL in momentum and scale, while SBRA appeals to income-focused investors seeking higher current yields within the same sector.
Introduction
Both SBRA and WELL operate as healthcare-focused real estate investment trusts (REITs), owning and managing properties that serve senior housing, medical offices, and related facilities. This comparison examines their business models, recent performance trends, and market positioning to assist investors and traders evaluating sector exposure. Participants in real estate investment strategies, income-oriented portfolios, or healthcare-adjacent equities may find the analysis relevant for assessing relative value and risk factors in the current environment. The review draws on observable financial metrics and developments from recent weeks without projecting future outcomes.
SBRA Overview and Recent Performance
SBRA, or Sabra Health Care REIT, Inc., focuses on owning and investing in healthcare real estate, primarily senior housing communities and medical facilities. In recent market activity, the stock has traded near $20 per share with a market capitalization of approximately $5 billion. Revenue showed year-over-year growth in the most recent quarter, supported by same-store net operating income improvements in managed senior housing. The company maintains a dividend yield near 6 percent, with analysts issuing a moderate buy consensus and average price targets around $22. Sentiment has reflected steady operational updates alongside broader sector dynamics, while the stock’s 52-week range spans roughly $17 to $23. Debt metrics and liquidity remain areas of ongoing monitoring amid acquisition activity.
WELL Overview and Recent Performance
WELL, or Welltower Inc., is a larger healthcare REIT with a diversified portfolio of senior housing, outpatient medical properties, and other healthcare assets. Recent market activity has seen the stock trade near $229 per share with a market capitalization exceeding $160 billion. The company has reported robust revenue expansion and sustained occupancy trends in key segments. Its dividend yield stands near 1.5 percent, accompanied by a buy consensus from analysts and price targets averaging above $260. Performance in recent weeks has benefited from scale advantages and platform growth, with the stock’s 52-week range extending from approximately $164 to $255. Institutional ownership and balance sheet metrics contribute to its positioning within the sector.
Trending AI Robots
Tickeron’s Trending AI Robots page highlights a curated selection of AI trading bots designed for various market conditions. Tickeron offers hundreds of AI Trading Bots that trade thousands of different tickers across equities, options, and other instruments, yet only the highest-performing and most suitable options for prevailing conditions earn placement in this section. Available bots exhibit a wide range of trading styles, strategies, timeframes, historical performance statistics, and ticker sets, with metrics such as win rates, drawdowns, and profitability varying by model. This diversity allows users to explore options aligned with specific risk tolerances or market views. Review the full selection on the Trending AI Robots page for detailed statistics and configuration details.
Head-to-Head Comparison
SBRA and WELL share exposure to the healthcare real estate sector but differ markedly in scale, with WELL commanding a substantially larger market capitalization and broader geographic and property-type diversification. Growth drivers for SBRA center on targeted acquisitions and senior housing occupancy, while WELL benefits from platform-wide expansion and larger transaction volumes. Recent momentum has favored WELL in total return metrics, though SBRA provides a higher current dividend yield that may suit income strategies. Risk factors include leverage levels, with SBRA showing comparatively higher debt-to-EBITDA ratios in available data, and sector-wide sensitivities to interest rates and demographic trends. Market sentiment reflects stronger institutional flows toward the larger WELL platform, creating trade-offs between yield and growth potential.
Tickeron AI Verdict
Based on observable factors including trend consistency, relative performance stability, and positioning within the healthcare REIT sector, Tickeron’s AI models would currently assign a higher probabilistic preference to WELL over SBRA. This assessment rests on WELL’s demonstrated scale advantages, stronger recent total returns, and broader diversification, which align with patterns of sustained momentum in available data. SBRA retains appeal through its elevated yield and operational updates, yet the models indicate comparatively lower consistency in momentum signals. Investors should evaluate these probabilistic indicators alongside individual portfolio objectives.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBRA is a Hold and WELL is a Hold.
SBRA sees its Stochastic Oscillator climbs out of oversold territory
On October 12, 2026, the Stochastic Oscillator for SBRA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In 43 of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SBRA's RSI Indicator exited the oversold zone, 14 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on SBRA as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for SBRA just turned positive on October 14, 2026. Looking at past instances where SBRA's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Following a +0.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBRA advanced for three days, in 209 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
SBRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
SBRA moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SBRA crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
The Aroon Indicator for SBRA entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.796) is normal, around the industry mean (3.199). P/E Ratio (74.385) is within average values for comparable stocks, (44.369). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (1.649). Dividend Yield (0.062) settles around the average of (0.053) among similar stocks. P/S Ratio (5.889) is also within normal values, averaging (6.013).
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. SBRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
WELL's RSI Indicator ascending out of oversold territory
The RSI Indicator for WELL moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 10 of the 13 cases the stock moved higher. This puts the odds of a move higher at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on WELL as a result. In 51 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for WELL just turned positive on October 13, 2026. Looking at past instances where WELL's MACD turned positive, the stock continued to rise in 29 of 42 cases over the following month. The odds of a continued upward trend are 69%.
WELL moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in 226 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
WELL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for WELL crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 23%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Aroon Indicator for WELL entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.646) is normal, around the industry mean (3.199). WELL has a moderately high P/E Ratio (105.788) as compared to the industry average of (44.369). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). WELL has a moderately low Dividend Yield (0.014) as compared to the industry average of (0.053). WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
SBRA | WELL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 18 | 3 | |
SMR RATING 1..100 | 88 | 86 | |
PRICE GROWTH RATING 1..100 | 55 | 43 | |
P/E GROWTH RATING 1..100 | 5 | 33 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SBRA's Valuation (16) in the Real Estate Investment Trusts industry is significantly better than the same rating for WELL (95). This means that SBRA’s stock grew significantly faster than WELL’s over the last 12 months.
WELL's Profit vs Risk Rating (3) in the Real Estate Investment Trusts industry is in the same range as SBRA (18). This means that WELL’s stock grew similarly to SBRA’s over the last 12 months.
WELL's SMR Rating (86) in the Real Estate Investment Trusts industry is in the same range as SBRA (88). This means that WELL’s stock grew similarly to SBRA’s over the last 12 months.
WELL's Price Growth Rating (43) in the Real Estate Investment Trusts industry is in the same range as SBRA (55). This means that WELL’s stock grew similarly to SBRA’s over the last 12 months.
SBRA's P/E Growth Rating (5) in the Real Estate Investment Trusts industry is in the same range as WELL (33). This means that SBRA’s stock grew similarly to WELL’s over the last 12 months.
| SBRA | WELL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 64% | 3 days ago 77% |
| Stochastic ODDS (%) | 3 days ago 77% | 3 days ago 50% |
| Momentum ODDS (%) | 3 days ago 74% | 3 days ago 65% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 69% |
| TrendWeek ODDS (%) | 3 days ago 64% | 3 days ago 64% |
| TrendMonth ODDS (%) | 3 days ago 55% | 3 days ago 60% |
| Advances ODDS (%) | 3 days ago 65% | 3 days ago 63% |
| Declines ODDS (%) | 14 days ago 53% | 18 days ago 46% |
| BollingerBands ODDS (%) | 3 days ago 72% | 3 days ago 75% |
| Aroon ODDS (%) | 3 days ago 60% | 3 days ago 46% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SBRA’s FA Score shows that 3 FA rating(s) are green while WELL’s FA Score has 2 green FA rating(s).
- SBRA’s FA Score: 3 green, 2 red.
- WELL’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SBRA’s TA Score shows that 6 TA indicator(s) are bullish while WELL’s TA Score has 6 bullish TA indicator(s).
- SBRA’s TA Score: 6 bullish, 4 bearish.
- WELL’s TA Score: 6 bullish, 4 bearish.
Price Growth
SBRA (@Publishing: Books/Magazines) experienced а +2.00% price change this week, while WELL (@Publishing: Books/Magazines) price change was +4.16% for the same time period.
The average weekly price growth across all stocks in the @Publishing: Books/Magazines industry was +0.57%. For the same industry, the average monthly price growth was -4.10%, and the average quarterly price growth was -1.07%.
Reported Earning Dates
SBRA is expected to report earnings on Nov 09, 2026.
WELL is expected to report earnings on Oct 26, 2026.
Industries' Descriptions
@Publishing: Books/Magazines (+0.57% weekly)The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SETH | 33.51 | 0.54 | +1.65% |
| ProShares Short Ether ETF (SETH) | |||
| FEZ | 65.85 | -0.20 | -0.30% |
| State Street SPDR EURO STOXX 50 ETF (FEZ) | |||
| JULB | 28.13 | -0.25 | -0.88% |
| Aptus July Buffer ETF (JULB) | |||
| TUR | 32.47 | -1.09 | -3.25% |
| iShares MSCI Turkey ETF (TUR) | |||
| LABU | 198.86 | -24.08 | -10.80% |
| Direxion Daily S&P Biotech Bull 3X ETF (LABU) | |||
SBRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SBRA has been closely correlated with CTRE. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SBRA jumps, then CTRE could also see price increases.
| Ticker / NAME | Correlation To SBRA | 1D Price Change % | ||
|---|---|---|---|---|
| SBRA | 100% | +0.26% | ||
| CTRE - SBRA | 70% Closely correlated | -0.11% | ||
| WELL - SBRA | 62% Loosely correlated | +0.09% | ||
| AHR - SBRA | 60% Loosely correlated | +0.42% | ||
| ADC - SBRA | 55% Loosely correlated | +0.72% | ||
| O - SBRA | 55% Loosely correlated | +0.95% | ||
More | ||||